The Opioid Abuse Risk Screener predicts aberrant same-day urine drug tests and 1-year controlled substance database checks: A brief report.

Journal: Health psychology open
Published Date:

Abstract

The Opioid Abuse Risk Screener was developed to support well-informed decision-making in opioid analgesic prescribing by extending the breadth of psychiatric risk factors evaluated relative to other non-clinician-administered measures. We examined the preliminary predictive validity of the Opioid Abuse Risk Screener relative to the widely used Screener and Opioid Assessment for Patients with Pain-Revised in predicting aberrant urine drug tests and controlled substance database checks. The Opioid Abuse Risk Screener is significantly different from the Screener and Opioid Assessment for Patients with Pain-Revised in predicting aberrant same-day urine drug tests ( = 2.912,  = 0.0036) and controlled substance database checks within 1 year of assessment ( = 3.731,  = 0.0002). Promising preliminary analyses using machine learning methods are also discussed.

Authors

  • Lynnette A Averill
    US Department of Veterans Affairs, USA.
  • Christopher L Averill
    US Department of Veterans Affairs, USA.
  • Lyndsay A Staley
    Brigham Young University, USA.
  • J L Ozawa-Kirk
    The University of Utah, USA.
  • John Sk Kauwe
    Brigham Young University, USA.
  • Patricia Henrie-Barrus
    The University of Utah, USA.

Keywords

No keywords available for this article.